BIIB

Biogen Inc. stock outperforms competitors despite losses on the day

Why Did KOD, RGEN, BIIB Stocks Rise To 52-Week Highs?

Can Biogen's Growth Portfolio Maintain Its Lead Over Legacy MS Drugs?

How Investors May Respond To Biogen (BIIB) Advancing At-Home LEQEMBI Pen And Kidney Disease Data

Chips Send Nasdaq To New Highs; Micron, Shopify, Biogen In Focus

Biogen stock hits 52-week high at 225.88 USD

Biogen: Growth Is Back, But It Came At A Price (NASDAQ:BIIB)

Is Biogen Stock Outperforming the S&P 500?

Biogen (BIIB) and AbbVie (ABBV) Get Wolfe Upgrades—Which Pharma Stock Has More Upside?

Biogen Eyes Wave of Phase III Readouts as It Expands Beyond Neuroscience

Biogen Sees Pivotal Pipeline Moment as It Expands Beyond Neurology

Biogen Inc. stock outperforms competitors on strong trading day

Biogen CEO: We are at that inflection point where we are on a path to sustainable revenue growth

Biogen at Wells Fargo healthcare conference: growth bets widen

Watch CNBC's full interview with Biogen CEO Christopher Viehbacher